Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
Yue L, Zhou J, Zhou Y, Yang X, Xie T, Yang M, Zhao H, Zhao Y, Yang T, Li H, Xiang H, Wang J, Lu S, Liu H, Zhao H, Wei X, Zhang Y, Xie Z. Yue L, et al. Among authors: lu s. Emerg Microbes Infect. 2021 Dec;10(1):2125-2127. doi: 10.1080/22221751.2021.1996210. Emerg Microbes Infect. 2021. PMID: 34666622 Free PMC article. No abstract available.
Animal models for SARS-CoV-2 infection and pathology.
Bi Z, Hong W, Yang J, Lu S, Peng X. Bi Z, et al. Among authors: lu s. MedComm (2020). 2021 Nov 16;2(4):548-568. doi: 10.1002/mco2.98. eCollection 2021 Dec. MedComm (2020). 2021. PMID: 34909757 Free PMC article. Review.
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.
Xie T, Lu S, He Z, Liu H, Wang J, Tang C, Yang T, Yu W, Li H, Yang Y, Yang H, Yue L, Zhou Y, Yang F, Luo Z, Li Y, Xiang H, Zhao Y, Wang J, Wang H, Long R, Kuang D, Tan W, Peng X, Li Q, Xie Z. Xie T, et al. Among authors: lu s. Signal Transduct Target Ther. 2022 Feb 25;7(1):61. doi: 10.1038/s41392-022-00920-4. Signal Transduct Target Ther. 2022. PMID: 35217639 Free PMC article.
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.
He Q, Mao Q, Peng X, He Z, Lu S, Zhang J, Gao F, Bian L, An C, Yu W, Yang F, Zhou Y, Yang Y, Li Y, Yuan Y, Yan X, Yang J, Wu X, Huang W, Li C, Wang J, Liang Z, Xu M. He Q, et al. Among authors: lu s. Signal Transduct Target Ther. 2022 Mar 3;7(1):69. doi: 10.1038/s41392-022-00926-y. Signal Transduct Target Ther. 2022. PMID: 35241645 Free PMC article.
Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells.
Hong W, Yang J, Zou J, Bi Z, He C, Lei H, He X, Li X, Alu A, Ren W, Wang Z, Jiang X, Zhong K, Jia G, Yang Y, Yu W, Huang Q, Yang M, Zhou Y, Zhao Y, Kuang D, Wang J, Wang H, Chen S, Luo M, Zhang Z, Lu T, Chen L, Que H, He Z, Sun Q, Wang W, Shen G, Lu G, Zhao Z, Yang L, Yang J, Wang Z, Li J, Song X, Dai L, Chen C, Geng J, Gou M, Chen L, Dong H, Peng Y, Huang C, Qian Z, Cheng W, Fan C, Wei Y, Su Z, Tong A, Lu S, Peng X, Wei X. Hong W, et al. Among authors: lu g, lu s, lu t. Cell Mol Immunol. 2022 May;19(5):577-587. doi: 10.1038/s41423-022-00845-6. Epub 2022 Mar 10. Cell Mol Immunol. 2022. PMID: 35273357 Free PMC article.
17,233 results
You have reached the last available page of results. Please see the User Guide for more information.